Related Articles
EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β‑catenin/E‑cadherin pathway
Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells
EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients
Downregulation of MiD49 contributes to tumor growth and metastasis of human pancreatic cancer
Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN